DRUGS & AGING

由Adis国际有限公司(现在是Wolters Kluwer Health的一部分)出版。石头:1170 - 229 x。《药物与老龄化》为您提供了关于老年人群药物使用、老年疾病和老年对药物治疗的影响的重要和最新的信息。通过提供同行评议的、公正的和可靠的数据,与衰老的药物帮助你的评论文章做出临床决策和治疗选择基于国际共识,让你了解在重要问题上,日期与新兴治疗方法,意识到特定的药物治疗的地方。该杂志的目的是促进老年人的最佳药物治疗，通过提供一个定期计划的评论文章，涵盖临床药理学和病人管理的最重要方面，在这个独特的群体。对药物治疗有影响的衰老过程中的生理变化也属于该杂志的研究范围。

Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1170-229X.Drugs & Aging provides you with important and current information on drug use in the aging population as well as diseases of the aging and the effects of aging on drug treatment. By providing peer reviewed, impartial and reliable data, the review articles in Drugs & Aging assist you in making clinical decisions and treatment choices based on international consensus, keeping you well informed on important issues, up to date with emerging treatments, and aware of the place of specific drugs in therapy. The Journal aims to promote optimum drug therapy in older adults by providing a regular programme of review articles covering the most important aspects of clinical pharmacology and patient management in this unique group. Physiological changes during aging which have implications for drug therapy also fall within the scope of the Journal.